date,title,source
Oct-18-18,FDA Advisory Committee Recommends Approval of Shires Prucalopride (SHP555) for Chronic Idiopathic Constipation,GlobeNewswire
Oct-18-18,Notice of Results,GlobeNewswire
Oct-18-18,Takeda gets Japanese approval for $62 billion Shire purchase,Reuters
Oct-18-18,Takeda gets Japan's approval for $62 billion Shire purchase,Reuters
Oct-18-18,Rule 2.9 Announcement,GlobeNewswire
Oct-19-18,Shire's drug for rare swelling disorder wins European panel green light,Reuters
Oct-19-18,"Investor Expectations to Drive Momentum within Motorola Solutions, Shire plc, Bitauto, GRIDSUM HOLDING, GW Pharmaceuticals, and Actinium Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Oct-19-18,Shire plc: CHMP Recommends EU Marketing Authorisation of lanadelumab for the Prevention of HAE Attacks,GlobeNewswire
Oct-19-18,Rule 2.9 Announcement,GlobeNewswire
Oct-22-18,Rule 2.9 Announcement,GlobeNewswire
Oct-23-18,Rule 2.9 Announcement,GlobeNewswire
Oct-24-18,Rule 2.9 Announcement,GlobeNewswire
Oct-26-18,Rule 2.9 announcement,GlobeNewswire
Oct-29-18,Takeda proposes sale of Shire drug to gain European approval,Reuters
Oct-30-18,Rule 2.9 announcement,GlobeNewswire
Nov-01-18,Edited Transcript of SHP.L earnings conference call or presentation 1-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-01-18,Director/PDMR Shareholding,GlobeNewswire
Nov-01-18,Shire: 3Q Earnings Snapshot,Associated Press
Nov-01-18,[$$] Shire 3Q Net Profit Falls on Taxes,The Wall Street Journal
Nov-01-18,3rd Quarter Results,GlobeNewswire
Nov-01-18,Total voting rights,GlobeNewswire
Nov-01-18,Rule 2.9 Announcement,GlobeNewswire
Nov-01-18,Form 8 (DD) - Flemming Ornskov,GlobeNewswire
Nov-05-18,Edited Transcript of SHP.L earnings conference call or presentation 1-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-05-18,Takeda CEO confident of investor backing for $62 billion Shire deal,Reuters
Nov-06-18,Edited Transcript of SHP.L earnings conference call or presentation 1-Nov-18 2:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Rule 2.9 Announcement,GlobeNewswire
Nov-07-18,[$$] Shire Spinout Mirum Pharmaceuticals Launches With $120 Million,The Wall Street Journal
Nov-07-18,Rule 2.9 Announcement,GlobeNewswire
Nov-08-18,Takeda Pharmaceutical Company Limited -- Moody's assigns A2 to Takeda's proposed notes; places rating under review for downgrade,Moody's
Nov-08-18,Takeda Hires Banks for Euro Bonds to Finance Shire Takeover,Bloomberg
Nov-09-18,Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources,Reuters
Nov-09-18,Exclusive: Takeda to win EU approval for $62 billion Shire deal - sources,Reuters
Nov-09-18,Merrimack (MACK) Suffers Wider-Than-Expected Loss in Q3,Zacks
Nov-09-18,Rule 2.9 Announcement,GlobeNewswire
Nov-12-18,Takeda's Shire takeover to bring $963 million fee bonanza,Reuters
Nov-12-18,"Takeda sets vote date, aims to close $62 billion Shire deal Jan. 8",Reuters
Nov-12-18,"Takeda sets vote date, aims to close $62 billion Shire deal on January 8",Reuters
Nov-13-18,Daniel Loeb Purchases 7 Stocks in 3rd Quarter,GuruFocus.com
Nov-14-18,"David Abrams Buys Shire, Boosts Lithia Motors",GuruFocus.com
Nov-14-18,David Abrams Buys 3 Stocks in 3rd Quarter,GuruFocus.com
Nov-14-18,Shire's Filing Accepted by FDA for Gattex's Label Expansion,Zacks
Nov-14-18,Rule 2.9 Announcement,GlobeNewswire
Nov-15-18,Takeda Pharmaceutical Company Limited -- Moody's assigns A2 to Takeda's proposed notes; places rating under review for downgrade,Moody's
Nov-16-18,[$$] Takeda dissident investors make last push to block Shire deal,Financial Times
Nov-16-18,Shire Announces New HELP Study(TM) Data for Lanadelumab in HAE at 2018 ACAAI Annual Scientific Meeting,GlobeNewswire
Nov-16-18,Rule 2.9 Announcement,GlobeNewswire
Nov-19-18,Takeda's Dissident Holders Keep Trying to Kill Shire Deal,Bloomberg
Nov-19-18,Takeda Moves Quickly to Sell Dollar Bonds for Shire Plc Deal,Bloomberg
Nov-20-18,"Takeda Heads to Shire Vote With Backing from EU, Advisory Groups",Bloomberg
Nov-20-18,"Shire-Takeda deal gets conditional EU approval, heads to shareholders",American City Business Journals
Nov-20-18,Shire plc: Phase I conditional clearance by the European Commission,GlobeNewswire
Nov-20-18,"EU approves Takeda buying Shire, on divestment condition",Reuters
Nov-20-18,Rule 2.9 Announcement,GlobeNewswire
Nov-21-18,Shire-Takeda Deal Gets Phase I Conditional European Approval,Zacks
Nov-21-18,"EU approves Takeda buying Shire, on divestment condition",Reuters
Nov-23-18,BLOCK LISTING SIX MONTHLY RETURN,GlobeNewswire
Nov-23-18,Rule 2.9 Announcement,GlobeNewswire
Nov-26-18,Form 8 (DD) - Shire plc,GlobeNewswire
Nov-27-18,Shire plc: JAMA Publishes Complete Results of Phase 3 HELP Study Evaluating Lanadelumab as a Preventive Treatment for Hereditary Angioedema,GlobeNewswire
Nov-27-18,Rule 2.9 Announcement,GlobeNewswire
Nov-28-18,"Report: Developing Opportunities within Liberty TripAdvisor, Chanticleer, Retrophin, Menlo Therapeutics, Shire plc, and Matthews International  Future Expectations, Projections Moving into 2018",GlobeNewswire
Nov-29-18,Rule 2.9 Announcement,GlobeNewswire
Nov-30-18,"The Daily Biotech Pulse: EC Nod For Shire, Mirati Gets FDA Clearance For Cancer Drug Trials, PhaseBio's First Earnings",Benzinga
Nov-30-18,"Shire Receives European Approval for TAKHZYRO (lanadelumab) subcutaneous injection, for the Preventive Treatment of Hereditary Angioedema",GlobeNewswire
Dec-03-18,Shire's Takhzyro Gets European Nod for Hereditary Angioedema,Zacks
Dec-03-18,Total voting rights,GlobeNewswire
Dec-03-18,Rule 2.9 Announcement,GlobeNewswire
Dec-04-18,Holding(s) in Company,GlobeNewswire
Dec-04-18,Rule 2.9 Announcement,GlobeNewswire
Dec-06-18,"Shire (SHPG), Takeda Shareholders Approve $62 Billion Merger",Zacks
Dec-06-18,Rule 2.9 Announcement,GlobeNewswire
Dec-07-18,Rule 2.9 Announcement,GlobeNewswire
Dec-11-18,"Shire, Abbott Labs May Pace Healthcare Stocks in 2019",TheStreet.com
Dec-11-18,Rule 2.9 Announcement,GlobeNewswire
Dec-12-18,Rule 2.9 Announcement,GlobeNewswire
Dec-13-18,Edited Transcript of SHP.L earnings conference call or presentation 31-Jul-18 1:00pm GMT,Thomson Reuters StreetEvents
Dec-13-18,Rule 2.9 Announcement,GlobeNewswire
Dec-14-18,Director/PDMR Shareholding,GlobeNewswire
Dec-14-18,Rule 2.9 Announcement,GlobeNewswire
Dec-17-18,"FDA approves Shires Motegrity (prucalopride), the only serotonin-4 receptor agonist for adults with Chronic Idiopathic Constipation (CIC)",GlobeNewswire
Dec-17-18,Takeda Pharmaceutical Company Limited -- Moody's downgrades Takeda to Baa2; outlook stable,Moody's
Dec-18-18,Biotechs Were Innovators In 2018: Here Are The Top New Molecules That Were Approved,Benzinga
Dec-18-18,Rule 2.9 Announcement,GlobeNewswire
